Antimicrobial Resistance Trends and Outbreak Frequency in United States Hospitals

Clinical Infectious Diseases

Volumn 38, Issue 1, 2004, Pages 78-85

  Diekema, Daniel J ^a,b   BootsMiller, Bonnie J ^a,b   Vaughn, Thomas E ^a   Woolson, Robert F ^a   Yankey, Jon W ^a   Ernst, Erika J ^a   Flach, Stephen D ^a,b   Ward, Marcia M ^a   Franciscus, Carrie L J ^a,b   Pfaller, Michael A ^a,b   Doebbeling, Bradley N ^a,b  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTAZIDIME; CIPROFLOXACIN; OXACILLIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; ENTEROCOCCUS; ESCHERICHIA COLI; HOSPITAL; HUMAN; KLEBSIELLA; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; UNITED STATES;

ANTI-BACTERIAL AGENTS; BACTERIA; BACTERIAL INFECTIONS; CROSS INFECTION; DATA COLLECTION; DISEASE OUTBREAKS; DRUG RESISTANCE, BACTERIAL; HOSPITALS; HUMANS; MICROBIAL SENSITIVITY TESTS; UNITED STATES;

EID: 9144221550     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/380457     Document Type: Article

References (35)

1. Centers for Disease Control and Prevention. 1992. Public health focus: surveillance, prevention and control of nosocomial infections. MMWR Morb Mortal Wkly Rep 1992; 41:783-7.
2. Diekema DJ, Pfaller MA, Schmitz FJ, et al. Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the SENTRY Antimicrobial Surveillance Program, 1997-1999. Clin Infect Dis 2001; 32(Suppl 2): S114-32.
3. Centers for Disease Control and Prevention. National Nosocomial Infections Surveillance (NNIS) system report, data summary from January 1992-June 2001, issued August 2001. Am J Infect Control 2001; 29: 404-21.
4. Edmond MB, Wallace SE, McClish DK, et al. Nosocomial bloodstream infections in United States hospitals: a three-year analysis. Clin Infect Dis 1999; 29:239-44.
5. Fridkin SK, Steward CD, Edwards JR, et al. Surveillance of antimicrobial use and antimicrobial resistance in US hospitals: Project ICARE Phase 2. Clin Infect Dis 1999; 29:245-52.
6. Centers for Disease Control and Prevention. Staphylococcus aureus resistant to vancomycin: United States, 2002. MMWR Morb Mortal Wkly Rep 2002; 51:565-7.
7. Centers for Disease Control and Prevention. Public health dispatch: vancomycin resistant Staphylococcus aureus, Pennsylvania 2002. MMWR Morb Mortal Wkly Rep 2002; 51:902.
8. Sahm DF, Marsilio MK, Piazza G. Antimicrobial resistance in key bloodstream bacterial isolates: electronic surveillance with the Surveillance Network Database - USA. Clin Infect Dis 1999; 29:259-63.
9. Winokur PL, Canton R, Casellas JM, Legakis N. Variations in the prevalence of strains expressing an extended-spectrum β-lactamase phenotype and characterization of isolates from Europe, the Americas and the Western Pacific region. Clin Infect Dis 2001; 32(Suppl 2): 594-103.
10. Low DE, Keller N, Barth A, Jones RN. Clinical prevalence, antimicrobial susceptibility, and geographic resistance patterns of enterococci: results from the SENTRY Antimicrobial Surveillance Program, 1997-1999. Clin Infect Dis 2001; 32(Suppl 2):S133-45.
11. Diekema DJ, Pfaller MA, Jones RN, Doern GV. Survey of bloodstream infections due to gram-negative bacilli: frequency of occurrence and antimicrobial susceptibility of isolates collected in the SENTRY Antimicrobial Surveillance Program, 1997. Clin Infect Dis 1999; 29: 595-607.
12. Jones ME, Mayfield DC, Thornsberry C, et al. Prevalence of oxacillin resistance in Staphylococcus aureus among inpatients and outpatients in the United States during 2000. Antimicrob Agents Chemother 2002; 46:3104-5.
13. Karlowsky JA, Kelly LJ, Thornsberry C, et al. Susceptibility to fluoroquinolones among commonly isolated gram-negative bacilli in 2000: TRUST and TSN data for the US. Int J Antimicrob Agents 2002; 19: 231-31.
14. Richards C, Emori TG, Edwards J, et al. Characteristics of hospitals and infection control professionals participating in the National Nosocomial Infections Surveillance System 1999. Am J Infect Control 2001; 29:400-3.
15. Lawton RM, Fridkin SK, Gaynes RP, McGowan JE Jr. Practices to improve antimicrobial use at 47 US hospitals: the status of the 1997 SHEA/IDSA position paper recommendations. Society for Healthcare Epidemiology of America/ Infectious Diseases Society of America. Infect Control Hosp Epidemiol 2000; 21:256-9.
16. Shlaes DM, Gerding DN, John JF, et al. Society for Healthcare Epidemiology and Infectious Diseases Society of America joint committee on the prevention of antimicrobial resistance: guidelines for the prevention of antimicrobial resistance in hospitals. Clin Infect Dis 1997; 25:584-99.
17. The Hospital Infection Control Practices Advisory Committee (HIC-PAC). Recommendations for preventing the spread of vancomycin resistance. Am J Infect Control 1995; 23:878-94.
18. Goldmann DA, Weinstein RA, Wenzel RP, et al. Strategies to prevent and control the emergence and spread of antimicrobial-resistant microorganisms in hospitals: a challenge to hospital leadership. JAMA 1996; 275:234-40.
19. Centers for Disease Control and Prevention. Campaign to prevent antimicrobial resistance in healthcare settings. 2002. Available at: http: //www.cdc.gov/drugresistance/healthcare/default.htm. Accessed 3 December 2003.
20. Bross IDJ. How to use ridit analysis. Biometrics 1958; 14:18-38.
21. StatXact user manual. Version 5.0.3. Cambridge, MA: Cytel Software, 2000.
22. Rubin RJ, Harrington CA, Poon A, Dietrich K, Greene JA, Moiduddin A. The economic impact of Staphylococcus aureus in New York City hospitals. Emerg Infect Dis 1999; 5:9-17.
23. Bach PB, Malak SF, Jurcic J, et al. Impact of infection by vancomycin-resistant Enterococcus on survival and resource utilization for patients with leukemia. Infect Control Hosp Epidemiol 2002; 23:471-4.
24. McGowan JE. Economic impact of antimicrobial resistance. Emerg Infect Dis 2001; 7:286-92.
25. I nstitute of Medicine. Antimicrobial drug resistance: issues and options. Workshop report. Washington, DC: National Academy Press, 1998.
26. American Society for Microbiology. Report of the ASM Task Force on antibiotic resistance. Antimicrob Agents Chemother 1995;(Suppl): 1-23.
27. Fridkin SK, Edwards JR, Tenover FC, et al. Antimicrobial resistance prevalence rates in hospital antibiograms reflect prevalence rates among pathogens associated with hospital-acquired infections. Clin Infect Dis 2001; 33:324-30.
28. Chin AE, Hedberg K, Cieslak PR, Cassidy M, Stefonek KR, Fleming DW. Tracking drug-resistant Streptococcus pneumoniae in Oregon: an alternative surveillance method. Emerg Infect Dis 1999; 5:688-93.
29. Fridkin SK, Hill HA, Volkova NV, et al. Temporal changes in prevalence of antimicrobial resistance in 23 US hospitals. Emerg Infect Dis 2002; 8: 697-701.
30. Wenzel RP, Thompson RL, Landry SM, et al. Hospital-acquired infections in intensive care unit patients: an overview with emphasis on epidemics. Infect Control 1983; 4:371-5.
31. Haley RW, Tenney JH, Lindsey JO, Garner JS, Bennett JV. How frequent are outbreaks of nosocomial infection in community hospitals? Infect Control 1985; 6:233-6.
32. Berens MJ. Infection epidemic carves deadly path. Chicago Tribune. 21 July 2002:A1.
33. Patterson JE, Hardin TC, Kelly CA, Garcia RC, Jorgensen JH. Association of antibiotic utilization measures and control of multiple-drug resistance in Klebsiella pneumoniae. Infect Control Hosp Epidemiol 2000; 21:455-8.
34. Pittet D, Hugonnet S, Harbath S, et al. Effectiveness of a hospital-wide programme to improve compliance with hand hygiene. Lancet 2000; 356:1307-12.
35. Centers for Disease Control and Prevention. Guideline for hand hygiene in health-care settings: recommendations of the Healthcare Infection Control Preactices Committee and the HICPAC/SHEA/APIC/ IDSA Hand Hygiene Task Force. Society for Healthcare Epidemiology of American/Association for Professionals in Infection Control/Infectious Diseases Society of America. MMWR Recomm Rep 2002; 51(RR-16):1-45, quiz CE1-4.